<DOC>
	<DOCNO>NCT03023202</DOCNO>
	<brief_summary>This study seek evaluate clinical utility Precision Medicine Molecular Tumor Board , track patient outcome .</brief_summary>
	<brief_title>UWCCC Molecular Tumor Board Registry</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Hematologic Neoplasms</mesh_term>
	<criteria>Clinically suspect histologically confirm solid hematological malignancy Undergoing genetic test tumor Ability understand write informed consent document Willingness sign write informed consent document Pediatric patient ( age &lt; 18 year ) exclude due lack expertise molecular tumor committee</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>